(0)
SIFI expands its presence in eastern Europe and northern Asia entering into a multi-year commercial agreement with Bausch Health Russia
CATANIA, Italy, May 17, 2021 /PRNewswire/ SIFI, a leading international ophthalmic company, announces it has entered into a strategic multi-year agreement with Bausch Health Russia to market its innovative products treating ophthalmic disorders in Russia.
Initial sales are expected in 2021, marketing 5 SIFI products, segments of a comprehensive and established ophthalmic portfolio. These include:
COLBIOCIN, NETTAVISC and NETTACIN, antibiotic solutions indicated for the treatment of external eye infections and available in multiple dosage forms;
OCTILIA, an eye-drop solution indicated for the treatment of irritations, reddening, ocular congestion and itching due to allergic, chemical or physical causes;
SIFI and Bausch Health Russia Announce Strategic Commercial Partnership that Will Ensure Greater Access to Important Eye Care Medicines in Russia prnewswire.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.co.uk Daily Mail and Mail on Sunday newspapers.